Fecal markers of environmental enteropathy and subsequent growth in Bangladeshi children

American Journal of Tropical Medicine and Hygiene

Volumn 95, Issue 3, 2016, Pages 694-701

  Arndt, Michael B ^a   Richardson, Barbra A ^a   Ahmed, Tahmeed ^c   Mahfuz, Mustafa ^c   Haque, Rashidul ^c   John Stewart, Grace C ^a,b   Denno, Donna M ^a,b,c   Petri, William A ^d   Kosek, Margaret ^e,f   Walson, Judd L ^a,b,c,g  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^d UNIVERSITY OF VIRGINIA   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^g The Childhood Acute Illness and Nutrition Network (CHAIN)   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; MYELOPEROXIDASE; NEOPTERIN; BIOLOGICAL MARKER; PEROXIDASE; SERPINA1 PROTEIN, HUMAN;

ADULT; ARTICLE; BANGLADESHI; CHILD; CHILD GROWTH; DIARRHEA; ENTERITIS; ENTEROPATHY; ENVIRONMENTAL DISEASE; FECES; FECES ANALYSIS; FEMALE; HUMAN; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; URBAN AREA; BANGLADESH; CHEMISTRY; COMPLICATION; DIARRHEA, INFANTILE; EPIDEMIOLOGY; GROWTH DISORDERS; INFANT; INTESTINAL DISEASES; NEWBORN; PRESCHOOL CHILD;

ALPHA 1-ANTITRYPSIN; BANGLADESH; BIOMARKERS; CHILD, PRESCHOOL; DIARRHEA, INFANTILE; FECES; FEMALE; GROWTH DISORDERS; HUMANS; INFANT; INFANT, NEWBORN; INTESTINAL DISEASES; MALE; NEOPTERIN; PEROXIDASE; PROSPECTIVE STUDIES;

EID: 84984819722     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.16-0098     Document Type: Article

References (36)

1. de Onis M, Blössner M, Borghi E, 2012. Prevalence and trends of stunting among pre-school children, 1990-2020. Public Health Nutr 15: 142-148.
2. Olofin I, McDonald CM, Ezzati M, Flaxman S, Black RE, Fawzi WW, Caulfield LE, Danaei G; Nutrition Impact Model Study (anthropometry cohort pooling), 2013. Associations of suboptimal growth with all-cause and cause-specific mortality in children under five years: a pooled analysis of ten prospective studies. PLoS One 8: e64636.
3. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE; Child Health Epidemiology Reference Group of WHO and UNICEF, 2012. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379: 2151-2161.
4. Bhutta ZA, Ahmed T, Black RE, Cousens S, Dewey K, Giugliani E, Haider BA, Kirkwood B, Morris SS, Sachdev HP, Shekar M, Maternal and Child Undernutrition Study Group, 2008. What works? Interventions for maternal and child undernutrition and survival. Lancet 371: 417-440.
5. Victora CG, Adair L, Fall C, Hallal PC, Martorell R, Richter L, Sachdev HS; Maternal and Child Undernutrition Study Group, 2008. Maternal and child undernutrition: consequences for adult health and human capital. Lancet 371: 340-357.
6. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, Ezzati M, Grantham-McGregor S, Katz J, Martorell R, Uauy R; Maternal and Child Nutrition Study Group, 2013. Maternal and child undernutrition and overweight in lowincome and middle-income countries. Lancet 382: 427-451.
7. Berkman D, Lescano A, Gilman R, Lopez S, Black M, 2002. Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet 359: 564-571.
8. Mendez M, Adair L, 1999. Severity and timing of stunting in the first two years of life affect performance on cognitive tests in late childhood. J Nutr 129: 1555-1562.
9. Powell C, Walker S, Himes J, Fletcher P, Grantham-McGregor S, 1995. Relationships between physical growth, mental development and nutritional supplementation in stunted children: the Jamaican study. Acta Paediatr 84: 22-29.
10. Dewey K, Begum K, 2011. Long-term consequences of stunting in early life. Matern Child Nutr 7 (Suppl 3): 5-18.
11. Ozaltin E, Hill K, Subramanian S, 2010. Association of maternal stature with offspring mortality, underweight, and stunting in low- to middle-income countries. JAMA 303: 1507-1516.
12. Keusch GT, Denno DM, Black RE, Duggan C, Guerrant RL, Lavery JV, Nataro JP, Rosenberg IH, Ryan ET, Tarr PI, Ward H, Bhutta ZA, Coovadia H, Lima A, Ramakrishna B, Zaidi AKM, Hay Burgess DC, Brewer T, 2014. Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequences. Clin Infect Dis 59: S207-S212.
13. Humphrey JH, 2009. Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet 374: 1032-1035.
14. Korpe PS, Petri WA, 2012. Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med 18: 328-336.
15. Guerrant RL, Oriá RB, Moore SR, Oriá MO, Lima AA, 2008. Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev 66: 487-505.
16. Denno DM, VanBuskirk K, Nelson ZC, Musser CA, Hay Burgess DC, Tarr PI, 2014. Use of the lactulose to mannitol ratio to evaluate childhood environmental enteric dysfunction: a systematic review. Clin Infect Dis 59: S213-S219.
17. Kosek M, Guerrant RL, Kang G, Bhutta Z, Yori PP, Gratz J, Gottlieb M, Lang D, Lee G, Haque R, Mason CJ, Ahmed T, Lima A, Petri WA, Houpt E, Olortegui MP, Seidman JC, Mduma E, Samie A, Babji S; MAL-ED Network Investigators, 2014. Assessment of environmental enteropathy in the MAL-ED cohort study: theoretical and analytic framework. Clin Infect Dis 59: S239-S247.
18. Kosek M, Haque R, Lima A, Babji S, Shrestha S, Qureshi S, Amidou S, Mduma E, Lee G, Yori PP, Guerrant RL, Bhutta Z, Mason C, Kang G, Kabir M, Amour C, Bessong P, Turab A, Seidman J, Olortegui MP, Quetz J, Lang D, Gratz J, Miller M, Gottlieb M; MAL-ED Network, 2013. Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am J Trop Med Hyg 88: 390-396.
19. Peterson KM, Buss J, Easley R, Yang Z, Korpe PS, Niu F, Ma JZ, Olortegui MP, Haque R, Kosek MN, Petri WA, 2013. REG1B as a predictor of childhood stunting in Bangladesh and Peru. Am J Clin Nutr 97: 1129-1133.
20. Widner B, Wirleitner B, Baier-Bitterlich G, Weiss G, Fuchs D, 2000. Cellular immune activation, neopterin production, tryptophan degradation and the development of immunodeficiency. Arch Immunol Ther Exp (Warsz) 48: 251-258.
21. Wagner M, Peterson CG, Ridefelt P, Sangfelt P, Carlson M, 2008. Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease. World J Gastroenterol 14: 5584-5589, discussion 5588.
22. Peterson CG, Eklund E, Taha Y, Raab Y, Carlson M, 2002. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am J Gastroenterol 97: 1755-1762.
23. Hill RE, Hercz A, Corey ML, Gilday DL, Hamilton JR, 1981. Fecal clearance of alpha 1-antitrypsin: a reliable measure of enteric protein loss in children. J Pediatr 99: 416-418.
24. Bernier JJ, Florent C, Desmazures C, Aymes C, L'Hirondel C, 1978. Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin. Lancet 2: 763-764.
25. Karbach U, Ewe K, Bodenstein H, 1983. Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease. Gut 24: 718-723.
26. Wiria AE, Prasetyani MA, Hamid F, Wammes LJ, Lell B, Ariawan I, Uh HW, Wibowo H, Djuardi Y, Wahyuni S, Sutanto I, May L, Luty AJ, Verweij JJ, Sartono E, Yazdanbakhsh M, Supali T, 2010. Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study). BMC Infect Dis 10: 77.
27. Ahmed T, Mahfuz M, Islam MM, Mondal D, Hossain MI, Ahmed AS, Tofail F, Gaffar SA, Haque R, Guerrant RL, Petri WA, 2014. The MAL-ED cohort study in Mirpur, Bangladesh. Clin Infect Dis 59: S280-S286.
28. Investigators TM-EN, 2014. The MAL-ED study: a multinational and multidisciplinary approach to understand the relationship between enteric pathogens, malnutrition, gut physiology, physical growth, cognitive development, and immune responses in infants and children up to 2 years of age in resource-poor environments. Clin Infect Dis 59: S193-S206.
29. Richard SA, McCormick BJJ, Miller MA, Caulfield LE, Checkley W, 2014. Modeling environmental influences on child growth in the MAL-ED cohort study: opportunities and challenges. Clin Infect Dis 59: S255-S260.
30. Saiki T, 1998. Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease. Kurume Med J 45: 69-73.
31. Beckmann GT, Rüffer A, 2000. Mikroökologie des Darmes: Grundlagen, Diagnostik, Therapie [Microbiology of the Intestines: Basics, Diagnostics, Therapy]. Hannover, Germany: Schlütersche.
32. Ledjeff E, Artner-Dworzak E, Witasek A, Fuchs D, Hausen A, 2001. Neopterin concentrations in colon dialysate. Pteridines 12: 155-160.
33. Naylor C, Lu M, Haque R, Mondal D, Buonomo E, Nayak U, Mychaleckyj JC, Kirkpatrick B, Colgate R, Carmolli M, Dickson D, van der Klis F, Weldon W, Steven Oberste M, Ma JZ, Petri WA Jr, 2015. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine 2: 1759-1766.
34. Wardlaw TM, 2004. Low Birthweight: Country, Regional and Global Estimates. New York, NY: UNICEF.
35. Victora C, Onis M, Hallal P, Blössner M, Shrimpton R, 2010. Worldwide timing of growth faltering: revisiting implications for interventions. Pediatrics 125: e473-e480.
36. Dewey K, Adu-Afarwuah S, 2008. Systematic review of the efficacy and effectiveness of complementary feeding interventions in developing countries. Matern Child Nutr 4 (Suppl 1): 24-85.